Singapore Medical Group (SMG)

SINGAPORE (Mar 23): Tony Tan, non-executive chairman of Singapore Medical Group (SMG) co-founded Parkway Holdings in 1979 and was its managing director until 2000.

SINGAPORE (Mar 2): RHB is maintaining its “buy” call on Singapore Medical Group (SMG) with a target price of 68 cents, as the group’s turnaround is further validated by organic and inorganic growth.

SINGAPORE (Mar 1): UOB Kay Hian is maintaining its “buy” call on Singapore Medical Group (SMG) with a P/E-based target price of 83 cents, pegged to the peer average FY18 P/E ratio of 26.8 times.

SINGAPORE (Feb 28): Singapore Medical Group (SMG) announced that its FY17 earnings has increased by 250.8% to $8.50 million compared to $2.42 million in FY16.

SINGAPORE (Feb 6): RHB is maintaining its “buy” call on Singapore Medical Group (SMG) with a target price of 79 cents.

SINGAPORE (Jan 26): Singapore Medical Group now has the largest healthcare platform catering to the premium market segment.

SINGAPORE (Dec 20): Singapore’s healthcare sector is expected to face strong pricing competition from neighbouring countries, such as Malaysia and Thailand where patients are able to also receive quality medical treatment at a faction of the cost as com

SINGAPORE (Nov 30): Maybank Kim Eng is maintaining its “buy” call on Singapore Medical Group (SMG) with a target price of 78 cents on increasing market share and overseas expansion.

SINGAPORE (Oct 20): Maybank Kim Eng is maintaining its “buy” call on Singapore Medical Group with an unchanged target price of 78 cents which is pegged at 27 times FY18 earnings.

SINGAPORE (Oct 19): RHB is maintaining its “buy” call on Singapore Medical Group (SMG) with a target price of 79 cents, as the group announced new acquisitions and hires.